Deformable adjuvants can enhance immune activation in new vaccine design

Conventional vaccine adjuvants primarily rely on molecular binding and biochemical stimulation to activate immune responses, which often leads to limited efficacy in elderly or low-responsive populations. How to introduce physical regulation into immune activation remains an open challenge.